Enrolling
Medtronic CIP326
Medtronic CIP326
The main purpose of this cohort is to test the Digital Twin insulin delivery algorithm and the Meal Prediction algorithm.
Pediatric Diabetes
Enrolling
Protect – Type 1 Diabetes Study
Protect – Type 1 Diabetes Study
The Protect study will determine whether teplizumab slows the loss of β cells and preserves β cell function in children and adolescent 8-17 years old who have been diagnosed with T1D in the previous 6 weeks.
Can’t find a study that works for you?
Subscribe for Information on Other Studies
Fill out the form below an we will let you know when a study becomes available that you may be interested in:
